Edwards Lifesciences Corp (EW) Stock Rating

Edwards Lifesciences, spun off from Baxter International in 2000, designs, manufactures, and markets medical devices and equipment for advanced structural heart disease. It is a leader across key products including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. About 60% of its total sales come from outside the US.